International Vaccine Institute begins technology transfer of Oral Cholera Vaccine to Biological E Ruchika Sharma21 March 2024 12:48 PM ISTIVI will complete the technology transfer by 2025 and the oral cholera vaccine will be manufactured for India and international markets by Biological...
Bharat Biotech, IVI begin Chikungunya vaccine Phase 2, 3 trial in Costa Rica Ruchika Sharma25 Aug 2021 11:00 AM ISTHyderabad: The International Vaccine Institute (IVI) has announced that the first participant received Bharat Biotech's Chikungunya vaccine candidate...
Typhoid: Study confirms Vi-DT conjugate vaccine safe and effective in children Dr. Kamal Kant Kohli21 Sept 2020 7:30 AM ISTA new study conducted by IVI in collaboration with SK bioscience shows that single-dose and two-dose regimens of Vi-DT typhoid conjugate vaccine (TCV)...
Bharat Biotech, IVI get Rs 106 crore funding from CEPI for developing Chikungunya vaccine Ruchika Sharma5 Jun 2020 2:35 PM ISTThe consortium will be further supported with a grant of up to USD 2 million from the centre''s Ind-CEPI initiative which will fund the set-up of GMP...
